Download original image
Fig. 2. Comparison of death-censored graft survival rate between the high proteinuria and low proteinuria in the dnDSA (–) group (A) and dnDSA (+) group (B). CABMR, chronic active antibody-mediated rejection; dnDSA, de novo donor-specific antibody.
Korean J Transplant 2021;35:33~40 https://doi.org/10.4285/kjt.20.0052
© Korean Journal of Transplantation